Profusa (PFSA)announced that, by letter dated May 6, the Nasdaq Hearings Panel granted the company’s request to transfer the listing of its securities from The Nasdaq Global Market to The Nasdaq Capital Market. The company’s continued listing on Nasdaq is subject to the company’s satisfaction of certain interim milestones and, ultimately, the company’s compliance with the bid price and stockholders’ equity requirements for continued listing on the Capital Market tier by July 6.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFSA:
- Profusa Faces Nasdaq Listing Risk Amid Financing Amendments
- Profusa Announces PanOmics Assay Know-How Acquisition Agreement
- Profusa Secures New Convertible Note and Warrant Financing
- Profusa Amends Financing and Pursues PanOmics Acquisition
- Profusa announces $30M letter of intent for PanOmics diagnostic platform